NL-OMON23098招募中不适用
The correlation of factor VIII antibodies, measured with different assays, and factor VIII survival in patients with severe haemophilia A.
Radboud University Nijmegen Medical Centre0 个研究点目标入组 150 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 150
研究概览
简要总结
/A
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Inclusion criteria for patients with severe haemophilia A without inhibitors are:
- •1. Less than 1% factor VIII activity (severe clinical phenotype of haemophilia A);
排除标准
- •Exclusion criteria for patients with severe haemophilia A without inhibitors are:
- •1. Known allergy to plasma proteins;
研究者
相似试验
招募中
不适用
Dynamics of the anti-factor VIII antibody signature duringtreatment with emicizumabD66Hereditary factor VIII deficiencyDRKS00031196niversitätsklinikum Frankfurt, Klinik für Kinder- und Jugendmedizin, Klinische und Molekulare Hämostaseologie100
招募中
不适用
Dynamics of the Anti-factor VIII Antibody Signature During Treatment With EmicizumabSevere Hemophilia ASevere Hemophilia A With InhibitorSevere Hemophilia A Without InhibitorNCT05802836Christoph Königs100
撤回
不适用
The Relationship Between Clotting Factor VIII and Bleeding Adverse Reactions in Patients Under the Therapies of Thrombolysis, Anticoagulation and Anti-plateletBleedingIschemic StrokeNCT02677818Zhujiang Hospital
已完成
不适用
Clinical validation of Factor VIII allo-antibody assays in patients with hemophilia A. The correlation of factor VIII antibodies, measured with different assays, on factor VIII survival in patients with severe haemophilia A.Haemophilia A1006447710005330NL-OMON31749niversitair Medisch Centrum Sint Radboud50
撤回
不适用
Non Neutralizing Antibodies: Prevalence and CharacterizationHemophilia ANCT01541527University Hospital, Montpellier